World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
10201
World Ranking
3366
National Ranking
1555

Suyu Shu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Suyu Shu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 152 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Suyu Shu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Suyu Shu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Suyu Shu is affiliated with the University of Michigan-Ann Arbor in the United States. Their academic profile is characterized by research activity conducted under this primary affiliation.

There is no available data regarding specific recent papers, co-authors, or frequent publication venues linked to their scholarly output. Similarly, information about book publications, fields of study, subfields, or main topics addressed in their work is not provided.

Details about any awards or recognitions are absent as well.

As such, the available information primarily identifies Suyu Shu by their institutional association without further elaboration on research contributions or scholarly impact.

Best Publications

  • Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

    Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox

  • Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.

    James J. Mulé;Suyu Shu;Susan L. Schwarz;Steven A. Rosenberg

  • Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

    Jørgen Kjærgaard;Junta Tanaka;Julian A. Kim;Kevin Rothchild

  • Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

    Hirohisa Yoshizawa;Alfred E. Chang;Suyu Shu

  • Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes.

    Hiroshi Tanaka;Junta Tanaka;Jørgen Kjaergaard;Suyu Shu

  • Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

    J. J. Mule;J. C. Yang;R. L. Afreniere;Suyu Shu

  • Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

    A E Chang;A Aruga;M J Cameron;V K Sondak

  • CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.

    Peter A. Cohen;Liaomin Peng;Gregory E. Plautz;Julian A. Kim

  • Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors

    Gary J. Nabel;Alfred Chang;Elizabeth G. Nabel;Gregory Plautz

  • Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.

    Satoshi Watanabe;Katsuya Deguchi;Rongxiu Zheng;Hidemasa Tamai

  • Systemic T cell adoptive immunotherapy of malignant gliomas

    Gregory E. Plautz;Gene H. Barnett;David W. Miller;Bruce H. Cohen

  • T cell adoptive immunotherapy of newly diagnosed gliomas.

    Gregory E. Plautz;David W. Miller;Gene H. Barnett;Glen H. J. Stevens

  • Infiltration of Tumors by Systemically Transferred Tumor-Reactive T Lymphocytes Is Required for Antitumor Efficacy

    Shigehiko Mukai;Jørgen Kjærgaard;Suyu Shu;Gregory E. Plautz

  • CXC Chemokine Ligand 9/Monokine Induced by IFN-γ Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors

    Anton V. Gorbachev;Hirohito Kobayashi;Daisuke Kudo;Charles S. Tannenbaum

  • Purification of L-Selectin low Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T Lymphocytes

    Hiroshi Kagamu;Suyu Shu

  • Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

    Maria R. Parkhurst;Cormac DePan;John P. Riley;Steven A. Rosenberg

  • Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.

    Julian A. Kim;Bruce J. Averbook;Kathleen Chambers;Kevin Rothchild

  • Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.

    Alfred E. Chang;Hirohisa Yoshizawa;Keisuke Sakai;Mark J. Cameron

  • Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.

    S Y Shu;T Chou;K Sakai

  • Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

    Jørgen Kjaergaard;Liaomin Peng;Peter A. Cohen;Judith A. Drazba

Frequent Co-Authors

Peter A. Cohen
Peter A. Cohen Mayo Clinic
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Vernon K. Sondak
Vernon K. Sondak University of South Florida
Gene H. Barnett
Gene H. Barnett Cleveland Clinic
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
John F. Tisdale
John F. Tisdale National Institutes of Health
Xin Yuan Fu
Xin Yuan Fu National University of Singapore
Elizabeth G. Nabel
Elizabeth G. Nabel Brigham and Women's Hospital
Leaf Huang
Leaf Huang University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can open diverse career opportunities. Nursing, especially psychiatric nurse practitioner roles, is a growing area that complements immunological knowledge. Prospective students often seek the easiest NP programs to get into to begin their advanced nursing education without excessive barriers.

Many online programs stand out for their quality clinical experiences. When choosing where to study, looking into the top online PMHNP programs ensures strong practical training and better job readiness.

Cost is another major factor for students. Thankfully, there are several affordable PMHNP programs that provide quality education without the heavy financial burden, making advanced nursing degrees more accessible.

Career outlook is promising, especially for those pursuing a Doctor of Nursing Practice (DNP). Understanding the highest paid DNP specialties can help guide students toward high-demand roles with competitive salaries, maximizing the return on their educational investment.

Best Scientists Citing Suyu Shu

Trending Scientists

Recently Published Articles